Hester Biosciences submits transcript of earnings conference call

10 Feb 2020 Evaluate

Hester Biosciences has informed that the Company submitted a transcript of Earnings Conference Call held by the Management of the Company with investors on Friday, 7 February 2020 at 2.00 pm to discuss the Standalone and Consolidated Unaudited Financial Results for the quarter and nine months ended on 31 December 2019.

The above information is a part of company’s filings submitted to BSE.

Hester Biosciences Share Price

1589.00 12.35 (0.78%)
31-Dec-2025 09:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1721.30
Dr. Reddys Lab 1262.05
Cipla 1494.40
Zydus Lifesciences 910.50
Lupin 2083.50
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×